ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
9 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
2.4K
|
774K
|
9
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Questions for upcoming Australian visit
|
|
GroRob
|
18 |
4.6K |
6 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
18
|
4.6K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Questions for upcoming Australian visit
|
|
GroRob
|
18 |
4.6K |
6 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
18
|
4.6K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Questions for upcoming Australian visit
|
|
GroRob
|
18 |
4.6K |
23 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
18
|
4.6K
|
23
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
2 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
2.4K
|
774K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
2 |
03/08/25 |
03/08/25 |
ASX - By Stock
|
2.4K
|
774K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
3 |
03/08/25 |
03/08/25 |
ASX - By Stock
|
2.4K
|
774K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Updated Corporate Presentation
|
|
GroRob
|
25 |
5.7K |
1 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
25
|
5.7K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
2 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GroRob
|
105 |
21K |
7 |
30/07/25 |
30/07/25 |
ASX - By Stock
|
105
|
21K
|
7
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
1 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
1 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
News, articles and interviews
|
|
GroRob
|
231 |
87K |
1 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
231
|
87K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
4 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
News, articles and interviews
|
|
GroRob
|
231 |
87K |
1 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
231
|
87K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Application for quotation of securities - ATH
|
|
GroRob
|
72 |
18K |
4 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
72
|
18K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Short activity
|
|
GroRob
|
10 |
5.3K |
4 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
10
|
5.3K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
1 |
12/07/25 |
12/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
1 |
12/07/25 |
12/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
2 |
08/07/25 |
08/07/25 |
ASX - By Stock
|
2.4K
|
774K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
A new PBT2 paper
|
|
GroRob
|
6 |
2.0K |
2 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
6
|
2.0K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity CEO to Provide Corporate Update on ATH434
|
|
GroRob
|
84 |
24K |
3 |
25/06/25 |
25/06/25 |
ASX - By Stock
|
84
|
24K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity CEO to Provide Corporate Update on ATH434
|
|
GroRob
|
84 |
24K |
8 |
25/06/25 |
25/06/25 |
ASX - By Stock
|
84
|
24K
|
8
|
|
ASX - By Stock
|
NXM |
Re:
Ann: Branches Gold Prospect Grows with Regional Aircore Success
|
|
GroRob
|
13 |
5.0K |
3 |
12/06/25 |
12/06/25 |
ASX - By Stock
|
13
|
5.0K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
2 |
03/06/25 |
03/06/25 |
ASX - By Stock
|
2.4K
|
774K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
GroRob
|
3 |
2.2K |
5 |
26/05/25 |
26/05/25 |
ASX - By Stock
|
3
|
2.2K
|
5
|
|
ASX - By Stock
|
ATH |
We have the bestest CEO
|
|
GroRob
|
6 |
2.9K |
5 |
16/05/25 |
16/05/25 |
ASX - By Stock
|
6
|
2.9K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Updated Corporate Presentation
|
|
GroRob
|
31 |
12K |
2 |
24/04/25 |
24/04/25 |
ASX - By Stock
|
31
|
12K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
6 |
09/04/25 |
09/04/25 |
ASX - By Stock
|
2.4K
|
774K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
ATH Chart Thread
|
|
GroRob
|
73 |
20K |
3 |
08/04/25 |
08/04/25 |
ASX - By Stock
|
73
|
20K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Ceasing to be a substantial holder
|
|
GroRob
|
4 |
1.8K |
2 |
25/03/25 |
25/03/25 |
ASX - By Stock
|
4
|
1.8K
|
2
|
|
ASX - By Stock
|
NXM |
Re:
Ann: Response to ASX Price and Volume Query
|
|
GroRob
|
35 |
14K |
7 |
25/03/25 |
25/03/25 |
ASX - By Stock
|
35
|
14K
|
7
|
|
ASX - By Stock
|
NXM |
Re:
Ann: Response to ASX Price and Volume Query
|
|
GroRob
|
35 |
14K |
5 |
24/03/25 |
24/03/25 |
ASX - By Stock
|
35
|
14K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
6 |
04/03/25 |
04/03/25 |
ASX - By Stock
|
2.4K
|
774K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
4 |
04/03/25 |
04/03/25 |
ASX - By Stock
|
2.4K
|
774K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
6 |
26/02/25 |
26/02/25 |
ASX - By Stock
|
2.4K
|
774K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
GroRob
|
507 |
164K |
10 |
24/02/25 |
24/02/25 |
ASX - By Stock
|
507
|
164K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
553,461 shorted shares in NY
|
|
GroRob
|
9 |
3.6K |
2 |
14/02/25 |
14/02/25 |
ASX - By Stock
|
9
|
3.6K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity raises A$40m to Advance ATH434 Development in MSA
|
|
GroRob
|
73 |
25K |
6 |
10/02/25 |
10/02/25 |
ASX - By Stock
|
73
|
25K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity raises A$40m to Advance ATH434 Development in MSA
|
|
GroRob
|
73 |
25K |
3 |
10/02/25 |
10/02/25 |
ASX - By Stock
|
73
|
25K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
GroRob
|
225 |
80K |
1 |
06/02/25 |
06/02/25 |
ASX - By Stock
|
225
|
80K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
GroRob
|
225 |
80K |
3 |
06/02/25 |
06/02/25 |
ASX - By Stock
|
225
|
80K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
GroRob
|
225 |
80K |
4 |
06/02/25 |
06/02/25 |
ASX - By Stock
|
225
|
80K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Raises Funds for ATH434 BD and Clinical Activities
|
|
GroRob
|
90 |
32K |
5 |
04/02/25 |
04/02/25 |
ASX - By Stock
|
90
|
32K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
0 |
31/01/25 |
31/01/25 |
ASX - By Stock
|
2.4K
|
774K
|
0
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
5 |
30/01/25 |
30/01/25 |
ASX - By Stock
|
2.4K
|
774K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
2 |
30/01/25 |
30/01/25 |
ASX - By Stock
|
2.4K
|
774K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
GroRob
|
507 |
164K |
6 |
30/01/25 |
30/01/25 |
ASX - By Stock
|
507
|
164K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
GroRob
|
507 |
164K |
3 |
30/01/25 |
30/01/25 |
ASX - By Stock
|
507
|
164K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
GroRob
|
2.4K |
774K |
3 |
30/01/25 |
30/01/25 |
ASX - By Stock
|
2.4K
|
774K
|
3
|
|